BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9138235)

  • 1. Early protection of puppies against canine parvovirus: a comparison of two vaccines.
    McCaw DL; Tate D; Dubovi EJ; Johnson JC
    J Am Anim Hosp Assoc; 1997; 33(3):244-50. PubMed ID: 9138235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ; Schultz RD
    Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroconversion of puppies to canine parvovirus and canine distemper virus: a comparison of two combination vaccines.
    Coyne MJ
    J Am Anim Hosp Assoc; 2000; 36(2):137-42. PubMed ID: 10730624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thoughts on vaccination protocols.
    McLaughlin MA
    J Am Vet Med Assoc; 2000 Nov; 217(10):1458-9. PubMed ID: 11128530
    [No Abstract]   [Full Text] [Related]  

  • 5. Thoughts on vaccination protocols.
    Petzel B
    J Am Vet Med Assoc; 2000 Nov; 217(10):1459. PubMed ID: 11128531
    [No Abstract]   [Full Text] [Related]  

  • 6. Response of puppies to canine-origin parvovirus vaccines.
    Carmichael LE; Pollock RV; Joubert JC
    Mod Vet Pract; 1984 Feb; 65(2):99-102. PubMed ID: 6328258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant?
    Larson LJ; Schultz RD
    Vet Ther; 2008; 9(2):94-101. PubMed ID: 18597247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
    McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
    J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of vaccination at 4 and 6 weeks in the control of canine parvovirus.
    De Cramer KG; Stylianides E; van Vuuren M
    Vet Microbiol; 2011 Apr; 149(1-2):126-32. PubMed ID: 21111542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus.
    Buonavoglia C; Cavalli A; Gravino E; Voigt V; Buonavoglia D; de Caprariis D
    Zentralbl Veterinarmed B; 1994 Mar; 41(1):3-8. PubMed ID: 7941844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs.
    Freisl M; Speck S; Truyen U; Reese S; Proksch AL; Hartmann K
    Vet J; 2017 Jan; 219():15-21. PubMed ID: 28093104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.
    Wilson S; Illambas J; Siedek E; Stirling C; Thomas A; Plevová E; Sture G; Salt J
    Vaccine; 2014 Sep; 32(42):5420-4. PubMed ID: 25148778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case report: effect of maternal antibodies on the vaccination against canine parvovirus].
    Schunck B; Truyen U
    Tierarztl Prax; 1995 Apr; 23(2):185-6. PubMed ID: 7624862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
    Siedek EM; Schmidt H; Sture GH; Raue R
    Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.
    Buonavoglia C; Cavalli A; Tempesta M; Voight V; Buonavoglia D; Corrente M; Sagazio P
    New Microbiol; 1995 Oct; 18(4):371-5. PubMed ID: 8590389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibodies to canine parvovirus and reaction to vaccination in client-owned, healthy dogs.
    Riedl M; Truyen U; Reese S; Hartmann K
    Vet Rec; 2015 Dec; 177(23):597. PubMed ID: 26514756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
    Litster A; Nichols J; Volpe A
    Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines.
    Bergman JG; Muniz M; Sutton D; Fensome R; Ling F; Paul G
    Vet Rec; 2006 Nov; 159(22):733-6. PubMed ID: 17127756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study.
    Vila Nova B; Cunha E; Sepúlveda N; Oliveira M; São Braz B; Tavares L; Almeida V; Gil S
    BMC Vet Res; 2018 Nov; 14(1):348. PubMed ID: 30445957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of canine parvovirus--a need for new vaccines?
    Truyen U
    Vet Microbiol; 2006 Oct; 117(1):9-13. PubMed ID: 16765539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.